Multicenter prospective study of stereotactic body radiotherapy for previously untreated solitary primary hepatocellular carcinoma: The STRSPH study-Reference-Cited by-同舟云学术

Multicenter prospective study of stereotactic body radiotherapy for previously untreated solitary primary hepatocellular carcinoma: The STRSPH study

Published:2021-03 Issue:4 Volume:51 Page:461-471
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Kimura Tomoki¹,Takeda Atsuya²,Sanuki Naoko²,Ariyoshi Keisuke³,Yamaguchi Takuhiro⁴,Imagumbai Toshiyuki⁵,Katoh Norio⁶^ORCID,Eriguchi Takahisa⁷,Oku Yohei²,Ozawa Shuichi¹,Tsurugai Yuichiro²,Kokubo Masaki⁵,Shimizu Shinichi⁸,Ishikura Satoshi⁹^ORCID

Affiliation:

1. Department of Radiation Oncology Hiroshima University Hospital Hiroshima Hiroshima Japan

2. Radiation Oncology Center Ofuna Chuo Hospital Kamakura Kanagawa Japan

3. Department of Data Management JORTC Data Center Arakawa‐ku Tokyo Japan

4. Division of Biostatistics Tohoku University Graduate School of Medicine Sendai Miyagi Japan

5. Department of Radiation Oncology Kobe City Medical Center General Hospital Kobe Hyogo Japan

6. Department of Radiation Oncology Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan

7. Department of Radiation Oncology Saiseikai Yokohamashi Tobu Hospital Yokohama Kanagawa Japan

8. Department of Radiation Medical Science and Engineering Faculty of Medicine Hokkaido University Sapporo Hokkaido Japan

9. Department of Radiology Nagoya City University Graduate School of Medical Sciences Nagoya Aichi Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13595

Reference37 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. Report of the 20th Nationwide follow‐up survey of primary liver cancer in Japan

3. A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).

4. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma;Journal of Clinical and Experimental Hepatology;2025-01

2. Initial Trans-Arterial Chemo-Embolisation (TACE) Is Associated with Similar Survival Outcomes as Compared to Upfront Percutaneous Ablation Allowing for Follow-Up Treatment in Those with Single Hepatocellular Carcinoma (HCC) ≤ 3 cm: Results of a Real-World Propensity-Matched Multi-Centre Australian Cohort Study;Cancers;2024-08-29

3. Dynamic liver volume change in predicting hepatic decompensation and long‐term effects of stereotactic body radiation therapy;Journal of Gastroenterology and Hepatology;2024-05-02

4. Managing hepatocellular carcinoma across the stages: efficacy and outcomes of stereotactic body radiotherapy;Strahlentherapie und Onkologie;2024-04-30

5. Proton Beam Radiotherapy as a Curative Alternative to Radiofrequency Ablation for Newly Diagnosed Hepatocellular Carcinoma;Anticancer Research;2024-04-27